Smith & Nephew Q3 Revenues Rise; Confirms FY18 View - Quick Facts

(RTTNews) - Medical technology business Smith & Nephew plc (SN.L, SNN) reported Thursday that its third-quarter revenue was $1.169 billion, up 2% on a reported basis and 3% on an underlying basis.

Underlying revenue growth was 4% in the US, and 10% in the Emerging Markets

In its third-quarter trading update, the company reported strong growth in Reconstruction, Sports Medicine Joint Repair and Advanced Wound Devices. Meanwhile, advanced Wound Bioactives continued to decline.

Further, the company confirmed full-year guidance.

Namal Nawana, Chief Executive Officer, said, "Improved underlying revenue growth in the third quarter was led by growth in the US and Emerging Markets. We are on-track to deliver our full year guidance. These results were achieved whilst successfully redesigning how we will run the company. There is still more to do, and I am pleased with the pace of progress and engagement across the organisation."

The company is moving to new global commercial structure to unlock value through specialist global franchises.